Lisinopril
Product Images NDC 70934-613

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 70934-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 613 30 Master Bottle Label Approval Rev A 03 20)

Packaging label for Lisinopril Tablets USP 5 mg by Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label shows 30 tablets, directs Rx only, and includes storage instructions to keep out of reach of children, store in the original container, and protect from light, moisture, and freezing. The label also lists the NDC 70934-613-30 and dosage instructions to see the package insert.*

FDA Label Image

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)

Chemical structure of Lisinopril, showing its molecular composition including rings, amine groups, and carboxylic acid groups, along with two water molecules of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.